Estimation of proliferative potentiality of central neurocytoma: correlational analysis of minimum ADC and maximum SUV with MIB-1 labeling index

Abstract

Background

Central neurocytoma was initially believed to be benign tumor type, although atypical cases with more aggressive behavior have been reported. Preoperative estimation for proliferating activity of central neurocytoma is one of the most important considerations for determining tumor management.

Purpose

To investigate predictive values of image characteristics and quantitative measurements of minimum apparent diffusion coefficient (ADCmin) and maximum standardized uptake value (SUVmax) for proliferative activity of central neurocytoma measured by MIB-1 labeling index (LI).

Material and Methods

Twelve cases of central neurocytoma including one recurrence from January 2001 to December 2011 were included. Preoperative scans were conducted in 11, nine, and five patients for computed tomography (CT), diffusion-weighted imaging (DWI), and fluorine-18-fluorodeoxyglucose positron emission tomography (FDG-PET), respectively, and ADCmin and SUVmax of the tumors were measured. Image characteristics were investigated using CT, T2-weighted (T2W) imaging and contrast-enhanced T1-weighted (T1W) imaging, and their differences were examined using the Fisher's exact test between cases with MIB-1 LI below and above 2%, which is recognized as typical and atypical central neurocytoma, respectively. Correlational analysis was conducted for ADCmin and SUVmax with MIB-1 LI. A P value <0.05 was considered significant.

Results

Morphological appearances had large variety, and there was no significant correlation with MIB-1 LI except a tendency that strong enhancement was observed in central neurocytomas with higher MIB-1 LI (P = 0.061). High linearity with MIB-1 LI was observed in ADCmin and SUVmax (r = −0.91 and 0.74, respectively), but only ADCmin was statistically significant (P = 0.0006).

Conclusion

Central neurocytoma had a wide variety of image appearance, and assessment of proliferative potential was considered difficult only by morphological aspects. ADCmin was recognized as a potential marker for differentiation of atypical central neurocytomas from the typical ones.

Keywords

Central neurocytoma central nervous system (CNS)brain MR diffusion positron emission tomography (PET)

Get full access to this article

View all access options for this article.

References

Hassoun

Gambarelli

Grisoli

. Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathol 1982; 56: 151–156.

Hassoun

Soylemezoglu

Gambarelli

. Central neurocytoma: a synopsis of clinical and histological features. Brain Pathol 1993; 3: 297–306.

Bertalanffy

Roessler

Koperek

. Recurrent central neurocytomas. Cancer 2005; 104: 135–142.

Takao

Nakagawa

Ohtomo

. Central neurocytoma with craniospinal dissemination. J Neurooncol 2003; 61: 255–259.

Soylemezoglu

Scheithauer

Esteve

. Atypical central neurocytoma. J Neuropathol Exp Neurol 1997; 56: 551–556.

Brat

Scheithauer

Eberhart

. Extraventricular neurocytomas: pathologic features and clinical outcome. Am J Surg Pathol 2001; 25: 1252–1260.

Rades

Fehlauer

Schild

. Treatment of atypical neurocytomas. Cancer 2004; 100: 814–817.

Zhang

Luo

Zhang

. Central neurocytoma: a clinicopathological and neuroradiological study. Neuroradiology 2004; 46: 888–895.

Chen

Zhou

Liu

. Central neurocytoma. J Clin Neurosci 2012; 19: 849–853.

10.

Kono

Inoue

Nakayama

. The role of diffusion-weighted imaging in patients with brain tumors. Am J Neuroradiol 2001; 22: 1081–1088.

11.

Bulakbasi

Guvenc

Onguru

. The added value of the apparent diffusion coefficient calculation to magnetic resonance imaging in the differentiation and grading of malignant brain tumors. J Comput Assist Tomogr 2004; 28: 735–746.

12.

Kocaoglu

Ors

Bulakbasi

. Central neurocytoma: proton MR spectroscopy and diffusion weighted MR imaging findings. Magn Reson Imaging 2009; 27: 434–440.

13.

Higano

Yun

Kumabe

. Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology 2006; 241: 839–846.

14.

Zulfiqar

Yousem

Lai

. ADC values and prognosis of malignant astrocytomas: does lower ADC predict a worse prognosis independent of grade of tumor?--a meta-analysis. Am J Roentgenol 2013; 200: 624–629.

15.

Le Bihan

. Apparent diffusion coefficient and beyond: what diffusion MR imaging can tell us about tissue structure. Radiology 2013; 268: 318–322.

16.

Padma

Said

Jacobs

. Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol 2003; 64: 227–237.

17.

Mineura

Sasajima

Itoh

. Blood flow and metabolism of central neurocytoma: a positron emission tomography study. Cancer 1995; 76: 1224–1232.

18.

Ohtani

Takahashi

Honda

. Central neurocytoma with unusually intense FDG uptake: case report. Ann Nucl Med 2001; 15: 161–165.

19.

Warmuth-Metz

Klein

Sorensen

. Central neurocytoma of the fourth ventricle. Case report. J Neurosurg 1999; 91: 506–509.

20.

Wharton

Antoun

Macfarlane

. The natural history of a recurrent central neurocytoma-like tumor. Clin Neuropathol 1998; 17: 136–140.

21.

Mackenzie

. Central neurocytoma: histologic atypia, proliferation potential, and clinical outcome. Cancer 1999; 85: 1606–1610.

22.

Vasiljevic

Francois

Loundou

. Prognostic factors in central neurocytomas: a multicenter study of 71 cases. Am J Surg Pathol 2012; 36: 220–227.

23.

Ashkan

Casey

D'Arrigo

. Benign central neurocytoma. Cancer 2000; 89: 1111–1120.

24.

Ogawa

Sugawara

Seki

. Central neurocytomas with MIB-1 labeling index over 10% showing rapid tumor growth and dissemination. J Neurooncol 2006; 79: 211–216.

25.

Kuchiki

Kayama

Sakurada

. Two cases of atypical central neurocytomas. Brain Tumor Pathol 2002; 19: 105–110.

26.

Lee

Agid

. Preoperative grading of presumptive low-grade astrocytomas on MR imaging: diagnostic value of minimum apparent diffusion coefficient. Am J Neuroradiol 2008; 29: 1872–1877.

27.

Yamasaki

Sugiyama

Ohtaki

. Glioblastoma treated with postoperative radio-chemotherapy: prognostic value of apparent diffusion coefficient at MR imaging. Eur J Radiol 2010; 73: 532–537.

28.

Kruer

Kaplan

Etzl

Jr . The value of positron emission tomography and proliferation index in predicting progression in low-grade astrocytomas of childhood. J Neurooncol 2009; 95: 239–245.